Schistosome infections induce significant changes in the host biliary proteome by Torre Escudero, Eduardo de la et al.
1 
Schistosome infections induce significant changes in the host biliary proteome. 1
2
Eduardo de la Torre-Escudero, Ricardo Pérez–Sánchez, Raúl Manzano-Román, Ana3
Oleaga*4
5
6
Parasitology Laboratory, Instituto de Recursos Naturales y Agrobiología de Salamanca7
(IRNASA, CSIC). Cordel de Merinas, 40-52, 37008 Salamanca, Spain.8
9
*Corresponding author:10
Dr. Ana Oleaga11
Parasitology Laboratory.12
Instituto de Recursos Naturales y Agrobiología (IRNASA, CSIC)13
Cordel de Merinas, 40-5214
37008 Salamanca, Spain15
16
Tel.: +34 923219606; fax: +34 92321960917
18
E-mail address: ana.oleaga@irnasa.csic.es19
20
[Postprint]
Journal of Proteomics  114(1): 71-82 (2015)
2 
Abstract  21
Schistosomiasis is a disease caused by blood trematodes affecting man and 22
animals that represents an important human health and veterinary problem. Main 23
damages caused by this infection are a consequence of the host inflammatory reaction 24
against the parasite eggs trapped inside the liver. Despite the hepatic pathology of 25
schistosomiasis is very well known, there is no specific studies dealing with the 26
schistosome infection effects on the biliary function. The purpose of this work was to 27
analyse the changes induced by Schistosoma bovis infection in the biliary proteome. For 28
this, whole gallbladders from S. bovis-infected and non-infected mice were dissected, 29
homogenized and fractionated by differential centrifugation. The resulting protein 30
fractions were resolved by SDS-PAGE, the gels were sliced, and the gel pieces analyzed 31
by LC-MS/MS. Altogether, we identified 1,937 proteins, which were classified 32
according to their “protein class” and “molecular function”, and then subjected to an 33
“Enrichment analysis”. The differences found in gallbladder proteomes between S. 34
bovis-infected and non-infected mice are analysed. We show that chronic schistosome 35
infections cause significant changes in the biliary proteome that may produce 36
physiological alterations and affect the therapeutic actions of drugs when administered 37
to human patients and animals with schistosomiasis. 38
39
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1. INTRODUCTION 44
45
Schistosomiasis is a severe parasitic disease affecting humans and animals in 46
many tropical and subtropical areas of the world that is caused by flukes of the genus 47
Schistosoma. Schistosoma bovis is a blood-dwelling fluke of ruminants that is 48
genetically and immunologically analogous to the important human pathogen 49
Schistosoma haematobium [1]. Like human schistosomes, S. bovis cercariae penetrate 50
the host body through the skin, reaching the skin’s capillary vessels. Subsequently, they51
migrate through the blood stream towards the lungs, where remain for several days as 52
schistosomulum larvae. Following this, the schistosomula travel to the portal vein and 53
mesenteric vessels, where they finally develop into the adult stage [2]. At this location, 54
the adult schistosome worms release large numbers of eggs, many of which pass 55
through the gut wall to the gut lumen and then exit the host with faeces. However, a 56
significant fraction (up to 50%) of the eggs do not pass through the intestinal mucosa 57
towards the lumen and are carried by the portal vein blood flow mainly toward the liver 58
sinusoids, where they remain trapped and induce granulomatous lesions and strong 59
immune responses, which typically result in portal hypertension and hepatic fibrosis [3].60
The murine model of schistosomiasis is characterised by portal fibrosis, with 61
limited to absent injury of hepatic parenchyma, significant vascular damage, and an62
apparently normal liver function [4, 5]. Recently, it has been reported that during the 63
chronic phase of schistosome infection in mice, the proteins associated with several 64
liver metabolic functions (i.e., the citric acid cycle, the fatty acid cycle and the urea 65
cycle) are markedly downregulated, while the proteins associated with stress responses, 66
acute phase reactants and structural components are all significantly upregulated [6, 7]. 67
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In addition, important alterations in the histology of the bile ducts in response to 68
entrapped eggs, including the formation of massive granulomas, have been reported, 69
although neither the underlying pathomechanisms  of these hepatic lesions nor the likely 70
changes in bile composition as consequence of such hepatic lesions have been studied 71
[8, 9].72
Bile is a biological fluid with a complex composition (bile salts, phospholipids, 73
cholesterol, bilirubin, inorganic salts and proteins) that is produced by hepatocytes and 74
transferred through the intrahepatic bile ducts to the gallbladder, where it is stored and 75
concentrated at an approximately ten-fold concentration. In response to meals, bile is 76
released into the duodenum through the common bile duct [10, 11]. Bile serves diverse 77
functions, ranging from metabolism to transport; it essentially helps to emulsify fats, 78
facilitating their digestion and absorption and as an excretion route for xenobiotics (e.g. 79
toxins and drugs) and endobiotics (e.g. cholesterol and bilirubin) [11].80
Since bile is produced in the liver, it can be speculated that the pathological 81
changes induced in the liver and the biliary system during schistosome infection would 82
be reflected as alterations in bile protein composition, and therefore in bile function. In 83
spite of this and its foreseeable physiological impact, there is no information concerning 84
the changes that schistosomal hepatopathy may elicit in the composition of bile.85
Accordingly, and bearing in mind the crucial functions of bile, in the present 86
work we were prompted to investigate whether the S. bovis infection induces changes in 87
the biliary proteome. To accomplish this, we applied a protocol aimed at reducing the 88
complexity of bile samples, thereby avoiding the presence of molecules that interfere89
with protein analysis, such as bile salts and lipids [10]. For this, whole gallbladders 90
from S. bovis-infected and non-infected mice were dissected, homogenized and 91
fractionated by differential centrifugation. The resulting protein fractions were resolved 92
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by SDS-PAGE, the gels were sliced, and the gel pieces analyzed by LC-MS/MS. 93
Altogether, in infected and non-infected mice we identified 1,937 proteins, which were 94
classified according to their “protein class” and “molecular function”, and then 95
subjected to an “Enrichment analysis”. The differences found in gallbladder proteomes 96
between S. bovis-infected and non-infected mice are discussed.97
98
2. MATERIALS AND METHODS. 99
100
2.1. Experimental animals and infection 101
Forty NMRI mice weighing 30-35 g (Harlan Laboratories Models, S.L.) were 102
used. These mice were distributed into two experimental groups of 20 mice per group: 103
G0 group of non-infected mice and G1 group of mice infected with S. bovis.104
Mouse infection with S. bovis was done by tail immersion with 200 S. bovis 105
cercariae for 60 min. Four months later, when the infections were fully established, all106
mice were autopsied and their gallbladders extracted and stored at -80 ºC until 107
processing.108
All animal manipulations were done according to the rules from the ethical and 109
animal welfare Committee from the Institution where the experiments were conducted 110
(IRNASA, CSIC), following the corresponding EU rules and regulations.111
112
2.2. Gallbladder protein extracts for proteomic analyses 113
The mouse gallbladders were collected and grouped in batches of 5 114
gallbladders/batch and processed for the preparation of protein extracts. Each batch was115
resuspended in PBS (pH = 7.4) containing a cocktail of proteinase inhibitors (Roche 116
Diagnostics) (PBS-I) and homogenized six times (2 min each) using an Ultra-Turrax 117
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T10 disperser (IKA-Werke) at full power. The homogenates were sonicated for 3 min, 118
and then subjected to a fractionation process by centrifugation to reduce the complexity 119
of the protein composition of samples and facilitate their proteomic analysis. First, the 120
homogenates were centrifuged at 17,000 xg and 4ºC for 30 min and the resulting 121
supernatants (S-1) and pellets (P-1) were recovered. Next, a fraction of the S-1 122
supernatants was centrifuged at 100,000 xg and 4ºC for 60 min and the new 123
supernatants (S-2) and pellets (P-2) were recovered. The pellets obtained in each 124
centrifugation step were resuspended in 100 µl of PBS-I. The protein concentration of 125
all the fractions (supernatants and pellets) was assessed using the BCA Protein Assay 126
Reagent kit (Pierce).127
Samples of 15 µg of each fraction (S-1, S-2, P-1 and P-2) were mixed with 4x 128
Laemmli buffer [12], heated to 90ºC for 3 min and centrifuged at 12,000 xg for 4 min. 129
The protein samples were then resolved by SDS-PAGE in 10% polyacrylamide gels and 130
stained either with Coomassie Blue (Coomassie Blue R-25 0.125%, methanol 50%, 131
acetic acid 10%) or silver stain, using the PlusOne Silver Staining Kit (GE Healthcare).  132
The silver-stained gels were digitalized with the ChemiDoc system (Bio-Rad) 133
and gel images were analysed with Image Lab software (Bio-Rad). The gel lanes 134
stained with Coomassie blue were sliced into 3 pieces and these slices were sent to the 135
Proteomic Service of the University of Valencia (Spain) for protein identification.136
137
2.3. In-gel enzymatic digestion and liquid chromatography and tandem mass 138
spectrometry (LC-MS/MS).139
For each G0 and G1 group, two independent batches of five gallbladders each 140
were subjected to enzymatic digestion and LC-MS/MS analysis. For all the samples, 141
technical replicas were obtained by injecting each sample twice.142
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Briefly, gel slices were conditioned with 50% acetonitrile, dried and digested 143
with sequencing grade trypsin (Promega) (20 ng/μl in 25 mM NH4HCO3) overnight at 144
37ºC. The reactions were stopped with 10% trifluoroacetic acid (TFA) at a final 145
concentration of 0.1%, and the supernatants were filtered through a 0.22 μm filter and 146
dried by centrifugation in a vacuum. The concentration of peptides was estimated by 147
UV spectrometry, assuming that a 1 mg/ml solution of proteins had an extinction148
coefficient of 1.1 absorbance units at 280 nm.149
The peptides extracted following in-gel digestion were resuspended in 6 μl of 150
5% acetonitrile, 0.1% TFA, and 5 μl of the sample was loaded onto a trap column 151
(NanoLC Column, 3μ C18-CL, 350 μm×0.5 mm, Eksigen) and desalted with 0.1% TFA 152
at a flow rate of 3 μl/min for 5 min. The peptides were then loaded onto an analytical153
column (LC Column, 3μ C18-CL, 75 μm×12 cm, Nikkyo) equilibrated in 5% 154
acetonitrile and 0.1% formic acid. The peptides eluted were analyzed with a nanoESI-155
Q-TOF mass spectrometer (5600 TripleTOF, ABSciex) in information-dependent 156
acquisition mode, in which a 0.25-s TOF MS scan from 350 to 1250 m/z was 157
performed, followed by 0.05-s product ion scans from 100 to 1500 m/z on the 50 most 158
intense 2-5 charged ions.159
160
2.4. Database searching and protein identification 161
Database searches were performed in the NCBInr Mus musculus database 162
(35,149,712 sequences; 12,374,887,350 residues) using the Mascot v2.2 (Matrix 163
Science) search engine. For the samples from the G1 group, an additional search was 164
performed in a custom-made Trematoda_EST database (2,472,666 sequences; 165
396,860,374 residues) using the nucleotide sequences published in the NCBI_EST 166
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database. This search was performed to evaluate the potential presence of proteins of 167
parasite origin.168
For the Mascot searches, the peak lists were generated directly from QSTAR 169
wiff files by Mascot Daemon v. 2.2.2 (Matrix Science) with Sciex Analyst import filter 170
options using the default parameters. Databases were searched using the following 171
parameters: tryptic specificity, allowing one missed cleavage and a tolerance on the 172
mass measurement of 70 ppm in MS mode and 0.6 Da for MS/MS ions. The 173
carbamidomethylation of Cys was set as a fixed modification, and Met oxidation and 174
Asn/Gln deamidation were set as variable modifications. The significance threshold was 175
set at 0.05 and proteins required at least two unique significant peptides to be 176
considered identified.177
Redundant identifications were eliminated and the keratins and 178
immunoglobulins found were excluded from the lists of identified proteins provided in 179
the Results section.180
181
2.5. Data analysis  182
Protein classification was performed according to the Gene Ontology (GO) 183
hierarchy using the Universal Protein Resource (UniProt) retrieval system184
(http://www.uniprot.org/). The “ID mapping” module for the UniProt was used to 185
transform the GI number to UniProt code, standardize proteins symbols, and associate 186
them with corresponding gene names, gene ontology categories and IDs, molecular187
functions, subcellular location and tissue specificity.188
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The classification and analysis of the proteins identified was performed using the 189
Panther classification system (http://www.pantherdb.org/) [13] and the “Enrichment 190
Analysis” module of the WEB-based GEne SeT AnaLysis Toolkit (WebGestalt) 191
(http://5ht-dev.accre.vanderbilt.edu/webgestalt) [14]. Enrichment analyses for the Gene 192
Ontology categories (biological process and molecular function) and for the biological 193
pathways in the Wikipathways database were carried out using the mmusculus_genome 194
database as reference set, the hypergeometric test as a statistical method, and BH as a195
multiple test adjustment method [15]. The significant level for the GO enrichment 196
analysis for biological process and molecular function was the top 10 categories, and for197
the Wikipathways enrichment analysis a significance of p <0.0001 and a minimum 198
number of 6 genes for each category were selected.199
200
3. RESULTS 201
202
3.1. Gallbladder protein extracts.  203
Gallbladders from the G0 and G1 mice were homogenized in batches of 5 and 204
these homogenates were fractionated by means of two consecutive centrifugations at 205
17,000 and 100,000 xg, respectively. Thus, we obtained 4 fractions: supernatants S-1 206
and S-2 and pellets P-1 and P-2. The proteins in each of these fractions were resolved 207
by SDS-PAGE and stained with silver for protein visualization. 208
Fig. 1 shows the results of this fractionation procedure, showing that the S-1 and 209
P-1 fractions had complex band patterns that covered a broad range of molecular sizes,210
and also revealing some differences in protein composition between the G0 and G1 211
mouse groups localized around 52 kDa for S-1 and between 34 and 42 kDa for P-1. 212
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Regarding fractions S-2 and P-2, their band patterns were less complex, although they 213
still showed differences between the G0 and G1 mice (Fig. 1).  214
After fractionation, for each fraction (S-1, P-1, S-2 and P-2) all batches of 215
gallbladders from the same mouse group (G0 or G1) showed identical band patterns to 216
that of the homologous fraction in Fig. 1 (not shown), demonstrating the reproducibility 217
of the procedure. 218
219
3.2. Proteins identified. 220
The results presented here are the sum of the identifications performed with 221
Mascot in the NCBInr_Mus musculus database in the two gallbladder batches (5 222
gallbladder/batch) analyzed from each group of mice (G0 and G1). In order to simplify 223
the comparative analysis between the G0 and G1 mice, these results do not include 224
keratins, immunoglobulins or immunoglobulin-like proteins.225
The proteomic analysis of all the gallbladder fractions -supernatants and pellets- 226
allowed the identification, on the basis of at least two significant peptides, of a total of 227
1,937 non-redundant proteins: 1,589 in the gallbladder of non-infected mice (G0) and 228
1,489 in the gallbladder of mice infected with S. bovis (G1). Of these proteins, 348 were 229
identified only in the gallbladder of the G1 group; 448 only in the G0 group, and 1141 230
in both groups of mice (Table 1 and Supplementary Table 1). 231
The number of non-redundant proteins identified in individual fractions ranged 232
between 300 and 1069, the S-1 fractions showing the highest values, followed by the P-233
1, P-2 and S-2 fractions. The only exception was the P-2 fraction from the G0 group, in 234
which up to 1,044 non-redundant proteins were identified (Table 1). 235
A search of the custom-made Trematoda_EST database with the samples from 236
the G1 mice (infected with S. bovis) identified a total of 189 non-redundant hits. The 237
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subsequent BLAST analysis of these sequences allowed us to identify 154 proteins and 238
35 hypothetical, unknown or non-characterized proteins (Supplementary Table 2). All 239
these identified proteins, most of them belonging to highly conserved protein families 240
such as actins, tubulins, heat shock proteins, histones, etc., had already been identified 241
in the NCBInr Mus musculus database, so that any of them could be considered of 242
parasite origin.243
The proteins identified in all the fractions from the same experimental group of 244
mice, either G0 or G1, were grouped and analyzed together. The proteins were 245
classified first by their “Protein Class” and “Molecular Function” using the Panther 246
Classification System, followed by an “Enrichment Analysis” with the Mus musculus247
genome as the reference set.  248
Protein classification. 249
The “Protein Class” classification of the biliary proteomes from S. bovis infected 250
and non-infected mice is shown in Fig. 2. For both groups of mice, G0 and G1, the 251
proteins were grouped in the same 28 protein classes, showing a very similar 252
distribution. The most numerous protein classes were oxidoreductases (17.6% in G0 and 253
15.7% in G1) and hydrolases (15.1% in G0 and 17.6% in G1), followed by transferases254
(13.1% in G0 and 11.8% in G1), nucleic acid-binding proteins (11.5% in G0 and 10.8% 255
in G1), enzyme modulators (7.3% in G0 and 8.8% in G1), cytoskeletal proteins (9.0% in 256
G0 and 8.6% in G1) and proteases (5.7% in G0 and 6.9% in G1). There were few257
differences in the protein class ratios between the G0 and G1 mice, being 258
oxidoreductases and transferases slightly more numerous in the non-infected mice (G0), 259
while hydrolases, proteases and enzyme modulators were slightly more enriched in the260
infected mice (G1).261
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An in deep analysis of the proteins classified as “oxidoreductase proteins” 262
identified in both groups revealed certain particularities, detailed below. In this “Protein 263
Class” 215 non-redundant proteins were included, of which 197 were identified in the 264
G0 group and 174 in G1. In a comparative analysis of the proteins included in the 265
“oxidoreductase proteins class” identified exclusively in each group, 41 in G0 and 18 in266
G1, the following were observed: (i) In both groups, G0 and G1, proteins involved in 267
different metabolic processes (carbohydrate metabolism, glycogen metabolism, 268
glycolysis, etc) were identified; (ii) 6 of the 7 proteins involved in immune 269
response/inflammation/stress response, were identified only in the G1 group; (iii) 270
proteins involved in lipid metabolism were only identified in the G0 group, and (iv) 8 271
of the 9 components involved in the respiratory electron transport chain, among which 272
several members of the Cytochrome P450 family were included, were identified only in 273
the samples from the G0 group (Supplementary Table 3).  274
Regarding these components of the Cytochrome P450 family (Cyp) in the 275
gallbladders of groups G0 and G1, of the 39 proteins of this family identified jointly in 276
both groups, all were identified in the G0 group but only 16 were present in the 277
gallbladders of the infected mice (G1) (see Supplementary Table 1).278
The additional “molecular function” classification of the identified proteins 279
resulted in the following categories: catalytic, binding, structural, antioxidant, enzyme 280
regulator, receptor, translation regulator, and transporter activity. In both groups of 281
mice, G0 and G1, the most numerous categories were those involving catalytic (49.1% 282
in G0 and 49.7% in G1), binding (21.3% in G0 and 21.4% in G1) and structural activity 283
(11.7% in G0 and 10.9% in G1). The remaining categories showed remarkably lower284
ratios, ranging between 0.8 % and 5.8% in the G0 mice and 0.7 % and 5.5% in the G1 285
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mice; in both mouse groups these ratios corresponded to proteins with antioxidant and 286
transporter activity, respectively.287
The proteins identified only in non-infected mice (G0), only in infected (G1) 288
mice, and in both groups of mice (G0 and G1), classified according to their molecular 289
function are summarized in Fig. 3. Proteins with catalytic function represented 46.3%, 290
50.0% and 49.6% of the identified proteins only in G0, only in G1, and in both groups, 291
respectively. Thus, to avoid masking the relative abundance of the other groups of 292
proteins represented, the catalytic activity category is not included in Fig 3. This figure 293
shows no differences between G1 and G0 groups in the percentage of proteins with 294
binding, antioxidant, receptor and transporter activity. By contrast, some differences 295
were observed between both groups of animals in the percentages of proteins with296
structural (13.3% in G0 versus 7.9% in G1) and translation regulator activity (4.7% in 297
G0 versus 0.8% in G1), which were both more numerous in G0 than in G1. Conversely, 298
proteins with enzyme regulator activity were more numerous in the G1 group (8%) than 299
in the G0 group (1.9%) (Fig. 3).300
Enrichment analysis of the proteins identified. 301
We used the Web-based Gene Set Analysis Toolkit (WebGestalt) to detect the 302
enriched biological pathways, biological processes and molecular functions associated 303
with the bile proteins identified in G0 and G1 groups.304
In the Fig. 4 we illustrate the ratio of enrichment of 48 biological pathways, with 305
a significance of p < 0.0001 and a minimum number of 6 genes for each category. Up to 306
39 of these 48 pathways proved to be significantly enriched in the gallbladder 307
proteomes of both groups of mice. For some of these 39 pathways, differences in their 308
enrichment ratios were observed between the mouse groups, being typically higher in 309
the G0 than in the G1 mice, and especially evident in the following pathways: oestrogen 310
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metabolism (29.74% in G0 versus 16.33% in G1), glucuronidation (29.34% in G0 311
versus 22.46% in G1), mitochondrial beta-oxidation (41.98% in G0 versus 35.32% in 312
G1) and oxidative stress (20.28% in G0 versus 13.61% in G1) (Fig. 4).  313
The remaining 9 pathways were differentially enriched in only one group. The 314
circadian exercise, irinotecan pathway, retinol metabolism and TGF-beta receptor 315
signalling pathway proved to be significantly enriched only in the G0 group, and the 316
EGFR1 signalling pathway, the FAS pathway, the IL-6 signalling pathway and T Cell 317
receptor signalling pathway were only enriched significantly in the G1 group.318
Table 2 shows the proteins involved in a representative group of enriched 319
pathways, e.g. the oestrogen metabolism, the irinotecan metabolism, the oxidative stress 320
and the TGF-beta receptor signalling pathways. As can be seen, some protein families, 321
such as the UDP-glucuronyl transferases, cytochrome P450, MAP kinase and NAD(P)H 322
dehydrogenase, were involved in several biological pathways. The proportion of 323
proteins identified in the G0 group with respect to those identified in G1, was always 324
higher in the former. Accordingly, this proportion (nº of proteins identified in the G0 325
group with respect to those identified in G1) was as follows: 1.6 in the oestrogen 326
metabolism pathway; 2.0 in the irinotecan pathway; 1.5 in oxidative stress, and 1.4 in 327
the TGF Receptor Signalling Pathway.328
Enrichment analyses for the Gene Ontology biological process and molecular 329
function are represented in Fig. 5. The biological processes that proved to be 330
significantly enriched in the gallbladder were all metabolic processes. The most 331
outstanding differences between G0 and G1 were: (i) the higher number of proteins 332
involved in the carbohydrate and monosaccharide metabolic processes identified in the 333
infected mice (G1) and, (ii) the higher number of proteins involved in coenzyme and334
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cofactor metabolic processes identified in the G0 group with respect to the G1 mice 335
(Fig. 5).336
Regarding molecular functions, the group of proteins significantly enriched in 337
the samples analyzed were those with a binding function and catalytic activity. As can338
be seen in Fig. 5, the most salient result was the greater number of genes with339
glutathione transferase activity present in the gallbladders of the G0 group as compared 340
with G1. Overall, we identified up to 19 members of different classes (alpha, mu, kappa, 341
pi and theta) of the glutathione S-transferase enzyme family, 15 in the gallbladders of 342
infected mice and up to 19 in the gallbladders of non-infected mice (see Supplementary 343
Table 1). 344
345
4. DISCUSSION 346
347
As stated in the introduction section, bile is a body fluid produced by the liver 348
that has digestive and excretion functions and its formation depends on the structural 349
and functional integrity of the bile-secretory apparatus [16, 17]. The main components 350
of bile are bile salts, fatty acids and cholesterol, corresponding to a protein content of351
only 7%. The sources of proteins in bile include plasma, hepatocytes and the epithelium 352
of the biliary tract and the gallbladder [17].353
Regarding schistosomiasis, there is in fact no evidence indicating that 354
schistosome infection elicits any kind of biliary disease. Indeed, only a few isolated 355
cases of patients with schistosomal cholecystitis and associated with concomitant 356
gallstones have been reported (less than 10 cases have been described in the medical 357
literature) [18-21]. Nevertheless, considering that schistosome infections cause 358
important liver lesions that also affect the bile secretory apparatus, it is highly likely that 359
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biliary secretion would be affected in infected animals. Moreover, since some biliary 360
proteins are produced by hepatocytes and the epithelium of the biliary tree, it could be 361
surmised that such infections might also modify the bile protein content. Accordingly, 362
and bearing in mind that there is little information about this aspect either, we were 363
prompted to determine whether any kind of change in the proteome of the gallbladder 364
might arise in mice infected with S. bovis for 4 months.365
Regarding the composition of bile, although the chemical composition of human 366
bile is well understood it is only recently when studies have begun to unravel its protein 367
constituents. In the last 10 years, in parallel with the development of proteomic 368
techniques, studies addressing human bile proteins have advanced considerably and we 369
now have available a comprehensive catalogue of biliary proteins [11]. The aims of 370
these studies have been to improve the understanding of the physiological processes 371
involved in the regulation of the hepato-biliary system; to explore the involvement of 372
bile proteins in health and disease, and to discover biomarkers for biliary tract 373
malignancies [10, 11, 17, 22-24]. Such work has also served to optimize protocols for 374
sample preparation and to solve the pitfalls involved in the proteomic analysis of bile 375
samples that result from the massive concentration of interfering compounds [17].376
In the present work we used a protocol to study the proteins present in bile 377
samples similar to that described by Farina et al. [10], based on sample fractionation by 378
serial centrifugation and acrylamide gel electrophoresis. The aim of this was to reduce379
the complexity of the bile samples before mass spectrometry and to limit unavoidable 380
losses related to other additional purification methods [17]. In this study with S. bovis381
we analyzed complete gallbladders instead of bile samples, as has been the case in other 382
studies addressing the human bile proteome, owing to the difficulty involved in 383
collecting bile samples from mice in sufficient quantity without being contaminated384
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with tissue proteins. This problem was exacerbated in the group of mice infected with S. 385
bovis, having these mice an apparent reduction in gallbladder volume (not shown), 386
effect that has already been reported in patients with portal hypertension due to 387
advanced Schistosoma mansoni infection [17].388
After processing the gallbladders of the infected and non-infected mice, the 389
small differences observed in the profile of the protein fraction bands (Fig. 1) afforded 390
the first indications of possible modifications in the biliary proteome due to S. bovis391
infection. The analysis by LC-MS/MS of these fractions revealed 1589 and 1489 non-392
redundant proteins in mice not infected and infected with S. bovis respectively. Bearing 393
in mind that we analyzed complete gallbladders, this number is compatible with the 812 394
proteins identified by Farina et al. [11] in a similar proteomic analysis of human bile.395
Initially, the comparison of the biliary proteomes from non-infected and infected 396
mice did not revealed important differences in either the number or the type of proteins397
identified, as inferred from the “Protein class classification” (see Fig 2). However, after 398
a more detailed analysis of some groups of proteins, such as those included in the 399
oxidoreductase class, together with the analysis of the enrichment of the wikipathways 400
and Gene Ontology categories, we did detect significant differences between the mice 401
infected and not infected with S. bovis. It should be noted that some of the differences 402
observed in the protein composition between the G0 and G1 groups could in fact 403
represent quantitative differences in the expression level of the proteins, since the least 404
abundant proteins would be below the threshold of detection by MS.405
The analysis and comparison of the respective proteomes revealed that several 406
biological pathways and relevant molecular functions were underrepresented in the 407
biliary proteome of the infected mice (G1 group). Thus, in the gallbladders of the 408
infected mice we observed the expression of a significantly lower number of proteins 409
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involved in several pathways, being especially relevant among them the irinotecan 410
pathway, oestrogen metabolism and oxidative stress. We also observed a lower number 411
of components with metabolic functions and of molecules with glutathione S-412
transferase activity (see Fig. 4 and 5).  Irinotecan (IRI) is an anti-proliferative cytotoxic 413
agent used to treat metastatic colorectal cancer that is metabolized in the liver and 414
converted to SN-38, the active metabolite [26]. Additionally, the liver -and other 415
peripheral tissues-is a site for the biosynthesis of oestrogens and it is also the main site 416
for further biotransformation [27]. Three of the hepatic biological processes that are 417
affected by S. bovis infection -namely irinotecan metabolism, the biosynthesis and 418
biotransformation of oestrogens and oxidative stress-involve several components of the 419
Cytochrome P450 family (CYP), glutathione S-transferase (GST) and the UDP 420
glucuronyltransferase family (UGT).421
Hepatic CYP, GST and UGT are three multigene families of enzymes that play a 422
critical role in the metabolism of many drugs and xenobiotics [28-30]. It has been 423
reported that the activities and levels of expression of these enzymes are altered by 424
inflammatory stimuli, including helminthic infections [31]. In this sense, it has been 425
shown that in chronic S. mansoni infection (late phase of schistosomiasis) the liver 426
content and activity of some isoforms of CYP, GST and UDP are downregulated and 427
these regulations seem to be associated with a greater induction of Th2 cytokines [32-428
35]. The biliary proteome of the mice infected with S. bovis studied in the present work 429
reflects a situation similar to that described for the liver, where the numbers of CYP,430
GST and UGT isoforms are underrepresented with respect to normal values (16 CYP, 431
15 GST and 12 UGT isoforms in gallbladder in mice infected with S. bovis; 39 CYP, 19 432
GST and 19 UGT isoforms in gallbladder from non-infected mice) (see Supplementary 433
Table 1). Our results corroborate those reported by other authors for the liver and show 434
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that the elimination of drugs via both CYP and phase II of drug metabolism such as 435
GST and UGT may be severely impaired during murine chronic schistosomiasis [35]. In 436
fact, it has been demonstrated that chronic S. mansoni infection influence the 437
pharmacokinetic profiles of some drugs, such as praziquantel, enpiroline and 438
mefloquine, leading to delayed clearance [36, 37]. Accordingly, given that 439
schistosomiasis is prevalent in countries where coinfection for diseases such as HIV or 440
malaria is common, it is important to ask how schistosomiasis affects the enzymes 441
responsible for the metabolism of drugs given to treat not only schistosomiasis but also 442
these coinfections [35].443
Regarding the signalling molecules and pathways significantly enriched in the 444
G1 group of infected animals (Fig.4), several observations deserve further comment, 445
including: (i) the upregulation of pathways involved in chronic inflammation induction 446
such as the EGFR1 and the IL-6 signalling pathways, which are cross-connected and 447
have important roles in the proliferation of key inflammatory hepatic cells. [38]; (ii) the448
upregulation of these two ways could in turn be related to the increase in the FAS-449
mediated apoptotic pathway also observed in our study, since inflammation is targeted 450
once activated the apoptotic cascade [39]; (iii) the increase in the cytokine IL-6 can also 451
be related to lipid metabolism disorders, in order to modulate them accordingly [40] and 452
(iv) concerning the observed increase in the T-cell receptor signalling pathway, it is well 453
established that schistosome infection promotes T-cell activation and a Th2-type 454
inflammatory pathology , which requires host T-cell receptor signals, favouring parasite 455
growth and development in the mammalian host [41, 42]. Then, the upregulation of this 456
signalling pathway in the gallbladder -and liver- would favour the Th2-type cells that 457
are critical during helminthic infections and support the deep effects of the parasite-458
induced inflammatory environment on the host. 459
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In sum the present work reports the first data on the proteome of the mouse 460
gallbladder and provides a comprehensive catalogue of biliary proteins that may be of 461
great use in other studies addressing biliary physiology and pathology. We show that 462
chronic schistosome infections cause significant changes in the biliary proteome that463
may produce physiological alterations and affect the therapeutic actions of drugs when 464
administered to human patients and animals with schistosomiasis. 465
466
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585
Figure captions 586
587
Figure 1. Silver-stained 10% polyacrylamide gels showing the protein fractions 588
obtained from gallbladder homogenates of non-infected (G0) and Schistosoma bovis-589
infected mice (G1). Gel lanes were sliced into 3 pieces and the resulting gel slices were 590
digested with trypsin and analyzed by LC-MS/MS. S-1 and P-1, supernatant and pellet 591
from gallbladder homogenate centrifugation at 17,000g for 30 min. S-2 and P-2, 592
supernatant and pellet from centrifugation of S-1 at 100,000g for 1 h.593
594
Figure 2. The proteins identified in the gallbladder from non-infected mice (G0) and 595
mice infected with Schistosoma bovis (G0) were classified in “Protein classes” using the 596
Panther Classification System. Bars represent the percentage of proteins in each protein 597
class relative to the total number of proteins in the group.598
599
Figure 3. Classification according to their molecular function of the proteins identified 600
only in non-infected mice (G0), only in mice infected with Schistosoma bovis (G1) and 601
in both groups of mice (G0 and G1). Pie charts represent the percentages of proteins in 602
each category without including the proteins with catalytic activity.603
604
Figure 4. Ratio of enrichment (R) of the 48 significantly enriched pathways associated 605
with proteins identified in the proteome of the gallbladders of non-infected (G0) and 606
Schistosoma bovis-infected (G1) mice. Significance criteria included p < 0.0001 and a 607
minimum number of 6 genes for each category.608
609
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Figure 5. Ratio of enrichment (R) of top 10 enriched biological processes and molecular 610
functions associated with proteins identified in the proteome of the gallbladders of non-611
infected (G0) and Schistosoma bovis-infected mice (G1). Significance criteria included612
p< 0.0001 and a minimum number of 6 genes for each category.613
614
Table 1. Number of unique proteins identified in the fractions of the gallbladder 
homogenates. Redundant identifications, keratins and immunoglobulins have been 
excluded. G0, non-infected mice; G1, mice infected with Schistosoma bovis.  
. 
Gallbladder fractions G0 G1
S-1 (17,000g supernatant) 998 1069
P-1 (17,000g pellet) 768 752
S-2 (10
5
g supernatant ) 300 379
P-2 (10
5
g pellet  ) 1044 757
TOTAL 1589 1489
Specific and shared 
identifications
Only G0 G0 and G1 Only G1
448 1141 348
Table1
Click here to download Table: Table 1.docx
Table 2. Proteins identified in the gallbladder of Schistosoma bovis infected (G1) and non-infected (G0) mice involved in the following 
biological pathways: Estrogen metabolism, Irinotecan pathway, Oxidative Stress and TGF-beta Receptor Signaling Pathway. 
Experimental 
group Uniprot ID
Gene 
ID Gene name Protein name Pathway
G0 P13745 14857 Gsta1 glutathione S-transferase, alpha 1 (Ya) Estrogen metabolism
G0 P00184 13076 Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 Estrogen metabolism, Oxidative Stress
G0 Q8VCT4 104158 Ces3 carboxylesterase 3 Irinotecan pathway
G0 Q5FW80 394430 Ugt1a10 UDP glycosyltransferase 1 family, polypeptide A10 Irinotecan pathway, Estrogen metabolism, Oxidative Stress
G0 P70691 22236 Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 Irinotecan pathway, Estrogen metabolism, Oxidative Stress
G0 Q8R0P3 394435 Ugt1a6b UDP glucuronosyltransferase 1 family, polypeptide A6B Irinotecan pathway, Estrogen metabolism, Oxidative Stress
G0 Q61133 14872 Gstt2 glutathione S-transferase, theta 2 Oxidative Stress
G0 P09671 20656 Sod2 superoxide dismutase 2, mitochondrial Oxidative Stress
G0 P28652 12323 Camk2b calcium/calmodulin-dependent protein kinase II, beta TGF-beta Receptor Signaling Pathway
G0 Q8K1M3 19087 Prkar2a protein kinase, cAMP dependent regulatory, type II alpha TGF-beta Receptor Signaling Pathway
G0 P07214 20692 Sparc secreted acidic cysteine rich glycoprotein TGF-beta Receptor Signaling Pathway
G0 Q6P5F9 103573 Xpo1 exportin 1, CRM1 homolog (yeast) TGF-beta Receptor Signaling Pathway
G1 Q64669 18104 Nqo1 NAD(P)H dehydrogenase, quinone 1 Estrogen metabolism, Oxidative Stress
G0, G1 B6VGH4 13077 Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 Estrogen metabolism
G0, G1 P10649 14862 Gstm1 glutathione S-transferase, mu 1 Estrogen metabolism
G0, G1 Q6XL48 394433 Ugt1a5 UDP glucuronosyltransferase 1 family, polypeptide A5 Irinotecan pathway, Estrogen metabolism, Oxidative Stress
G0, G1 Q6ZQM8 394432 Ugt1a7c UDP glucuronosyltransferase 1 family, polypeptide A7C Irinotecan pathway, Estrogen metabolism, Oxidative Stress
G0, G1 Q62452 394434 Ugt1a9 UDP glucuronosyltransferase 1 family, polypeptide A9 Irinotecan pathway, Estrogen metabolism, Oxidative Stress
G0, G1 Q64435 94284 Ugt1a6a UDP glucuronosyltransferase 1 family, polypeptide A6A Irinotecan pathway, Estrogen metabolism, Oxidative stress
G0, G1 P97494 14629 Gclc glutamate-cysteine ligase, catalytic subunit Oxidative Stress
G0, G1 P11352 14775 Gpx1 glutathione peroxidase 1 Oxidative Stress
G0, G1 P47791 14782 Gsr glutathione reductase Oxidative Stress
G0, G1 Q9JMH6 50493 Txnrd1 thioredoxin reductase 1 Oxidative Stress
Table 2
G0, G1 Q9JLT4 26462 Txnrd2 thioredoxin reductase 2 Oxidative Stress
G0, G1 Q6PHZ2 108058 Camk2d calcium/calmodulin-dependent protein kinase II, delta TGF-beta Receptor Signaling Pathway
G0, G1 Q9QZD9 54709 Eif3i eukaryotic translation initiation factor 3, subunit I TGF-beta Receptor Signaling Pathway
G0, G1 P47811 26416 Mapk14 MAP kinase 14 TGF-beta Receptor Signaling Pathway, Oxidative Stress
G0, G1 P49817 12389 Cav1 caveolin 1, caveolae protein TGF-beta Receptor Signaling Pathway
G0, G1 Q02248 12387 Ctnnb1 catenin (cadherin associated protein), beta 1 TGF-beta Receptor Signaling Pathway
G0, G1 P63017 15481 Hspa8 heat shock protein 8 TGF-beta Receptor Signaling Pathway
G0, G1 P70168 16211 Kpnb1 karyopherin (importin) beta 1 TGF-beta Receptor Signaling Pathway
G0, G1 Q9Z1Z2 20901 Strap serine/threonine kinase receptor associated protein TGF-beta Receptor Signaling Pathway
G0, G1 Q922Z3 68015 Trap1 TNF receptor-associated protein 1 TGF-beta Receptor Signaling Pathway
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